Trupanion, Inc. (NASDAQ:TRUP) Receives Consensus Recommendation of “Hold” from Brokerages

Shares of Trupanion, Inc. (NASDAQ:TRUP) have received a consensus recommendation of “Hold” from the six brokerages that are currently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, three have given a hold recommendation and two have given a buy recommendation to the company. The average 1-year price target among analysts that have covered the stock in the last year is $42.25.

Several analysts have issued reports on the company. Cantor Fitzgerald lowered their target price on Trupanion from $42.00 to $34.00 and set a “neutral” rating on the stock in a research note on Thursday, April 9th. Piper Sandler cut their price target on Trupanion from $60.00 to $45.00 and set an “overweight” rating for the company in a research note on Friday, February 13th. Weiss Ratings lowered Trupanion from a “hold (c-)” rating to a “sell (d+)” rating in a report on Wednesday, March 4th. Bank of America lowered their price objective on Trupanion from $63.00 to $59.00 and set a “buy” rating on the stock in a research note on Tuesday, April 14th. Finally, Stifel Nicolaus dropped their price objective on shares of Trupanion from $35.00 to $31.00 and set a “hold” rating on the stock in a report on Tuesday, March 31st.

Insider Activity

In related news, CFO Fawwad Qureshi sold 2,837 shares of the company’s stock in a transaction that occurred on Friday, February 27th. The shares were sold at an average price of $26.46, for a total transaction of $75,067.02. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CRO Emily Dreyer sold 7,792 shares of the firm’s stock in a transaction that occurred on Wednesday, March 4th. The stock was sold at an average price of $28.15, for a total transaction of $219,344.80. Following the completion of the transaction, the executive directly owned 35,627 shares of the company’s stock, valued at approximately $1,002,900.05. This trade represents a 17.95% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 21,503 shares of company stock valued at $578,537 over the last quarter. Company insiders own 5.42% of the company’s stock.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in TRUP. Royal Bank of Canada increased its position in shares of Trupanion by 60.6% during the first quarter. Royal Bank of Canada now owns 29,763 shares of the financial services provider’s stock valued at $1,109,000 after buying an additional 11,233 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of Trupanion by 4.6% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 19,603 shares of the financial services provider’s stock valued at $731,000 after acquiring an additional 858 shares during the period. Millennium Management LLC boosted its position in shares of Trupanion by 73.5% in the first quarter. Millennium Management LLC now owns 267,976 shares of the financial services provider’s stock valued at $9,987,000 after acquiring an additional 113,490 shares during the period. Invesco Ltd. grew its stake in Trupanion by 35.1% during the second quarter. Invesco Ltd. now owns 187,749 shares of the financial services provider’s stock valued at $10,392,000 after acquiring an additional 48,781 shares in the last quarter. Finally, Gabelli Funds LLC purchased a new position in Trupanion during the second quarter valued at approximately $249,000.

Trupanion Stock Down 3.8%

Trupanion stock opened at $24.61 on Friday. The firm has a 50 day moving average price of $26.20 and a 200-day moving average price of $32.46. The company has a quick ratio of 1.73, a current ratio of 1.73 and a debt-to-equity ratio of 0.25. Trupanion has a twelve month low of $23.80 and a twelve month high of $57.88. The company has a market capitalization of $1.07 billion, a P/E ratio of 41.71 and a beta of 1.49.

Trupanion (NASDAQ:TRUP) last posted its quarterly earnings results on Thursday, April 30th. The financial services provider reported $0.11 EPS for the quarter, topping analysts’ consensus estimates of $0.07 by $0.04. Trupanion had a net margin of 1.74% and a return on equity of 6.87%. The company had revenue of $384.05 million for the quarter, compared to analysts’ expectations of $379.77 million. During the same quarter in the previous year, the firm posted ($0.03) EPS. Trupanion’s revenue was up 12.3% on a year-over-year basis. As a group, equities analysts predict that Trupanion will post 0.53 EPS for the current year.

About Trupanion

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.